A study on the influence of emulsion droplet size on the skin penetration of tetracaine

Skin Pharmacology and Physiology

Volumn 20, Issue 5, 2007, Pages 263-270

  Izquierdo, P ^a   Wiechers, J W ^c,e   Escribano, E ^b   Garcia Celma M J ^a,b   Tadros, T F ^d   Esquena, J ^a   Dederen, J C ^e   Solans, C ^a  

^a DEPARTMENT OF ENVIRONMENTAL CHEMISTRY   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c Uniqema Skin R and D   (Netherlands)

^d Applied Research ^*

^e JW Solutions   (Belgium)

Author keywords

Dermal delivery; Emulsion droplet size; Nano emulsion; Percutaneous absorption; Skin penetration; Tetracaine; Transdermal delivery

Indexed keywords

SURFACTANT; TETRACAINE;

CONFERENCE PAPER; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; EMULSION; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; SKIN PENETRATION;

ADMINISTRATION, TOPICAL; ANESTHETICS, LOCAL; DRUG DELIVERY SYSTEMS; EMULSIONS; FEMALE; HUMANS; PARTICLE SIZE; SKIN; SKIN ABSORPTION; SURFACE PROPERTIES; SURFACE-ACTIVE AGENTS; TETRACAINE;

EID: 34548151313     PISSN: 16605527     EISSN: None     Source Type: Journal    
DOI: 10.1159/000106076     Document Type: Conference Paper

References (23)

1. Davis SS, Hadgraft J, Palin KJ: Medical and pharmaceutical applications of emulsions; in Becher P (ed): Encyclopedia of Emulsion Technology. New York, Dekker, 1985, vol 2, pp 159-238.
2. Donovan MD, Flanagan DR: Bioavailability of disperse dosage forms; in Lieberman HA, Rieger MM, Banker GS (eds): Pharmaceutical Dosage Forms. Disperse Systems. New York, Dekker, 1996, vol 1, pp 315-376.
3. Fernandez C, Marti-Mestres G, Ramos J, Maillols H: LC analysis of benzophenone-3. II. Application to determination of 'in vitro' and 'in vivo' skin penetration from solvents, coarse and submicron emulsions. J Pharm Biomed Anal 2000;24:155-165.
4. Förster T, Von Rybinski W: Applications of emulsions; in Binks BP (ed): Modern Aspects of Emulsion Science. London, The Royal Society of Chemistry, 1998, pp 395-426.
5. Lalor CB, Flynn GL, Weiner N: Formulation factors affecting release of drug from formulations. 1. Effect of emulsion type upon in-vitro delivery of ethyl p-amino-benzoate. J Pharm Sci 2000;83:1525-1528.
6. Friedman DI, Schwartz JS, Weisspapir M: Submicron emulsion vehicle for enhanced transdermal delivery of steroidal and nonsteroidal antiinflammatory drugs. J Pharm Sci 1995; 84: 324-329.
7. Schwarz JS, Weisspapir MR, Friedman DI: Enhanced transdermal delivery of diazepam by submicron emulsion creams. Pharm Res 1995; 12: 687-692.
8. Amselem S, Friedman D: Submicron emulsions as drug carriers for topical administration; in Benita S (ed): Submicron Emulsions in Drug Targeting and Delivery. Amsterdam, Harwood Academic Publishers, 1998, vol 9, pp 153-173.
9. Sonneville O, Simonnet JT, L'Alloret F: Nanoemulsions: a new vehicle for skincare products. Adv Colloid Int Sci 2004; 108-109: 145-149.
10. Ktistis G, Niopas I: A study on the in vitro percutaneous absorption of propranolol from disperse systems. J Pharm Pharmacol 1998;50:413-418.
11. Nokhodchi A, Nazemiyeh H, Ghafourian T, Hassan-Zadeh D, Valizadeh H, Bahary LAS: The effect of glycyrrhizin on the release rate and skin penetration of diclofenac sodium from topical formulations. Farmaco 2002; 57: 883-888.
12. Ropke C, Kaneko T, Rodrigues R, da Silva V, Barros S, Sawada T, et al: Evaluation of percutaneous absorption of 4-nerolidylcathecol from four topical formulations. Int J Pharm 2002; 249: 109-116.
13. Wissing SA, Müller RH: Cosmetic applications for solid lipid nanoparticles (SLN). Int J Pharm 2003; 254: 65-68.
14. Meguro K, Ueno M, Essumi K: Micelle formation in aqueous media; in Schick MJ (ed): Nonionic Surfactants. Physical Chemistry. Surfactant Science Series. New York, Dekker, 1987, vol 23, pp 109-183.
15. Franz TJ: Percutaneous absorption: on the relevance of in vitro data. J Invest Dermatol 1975; 64: 190-195.
16. Pinnagoda J, Tupker RA, Agner T, Serup J: Guidelines for transepidermal water-loss (TEWL) measurement - A report from the Standardization Group of the European Society of Contact Dermatitis. Contact Dermatitis 1990; 22: 164-178.
17. Okamoto H, Kamatsu H, Hashida M, Sezaki H: Effects of beta-cyclodextrin and di-omethyl-beta-cyclodextrin on the percutaneous absorption of butylparaben, indomethacin and sulphanylic acid. Int J Pharm 1986; 30:34-35.
18. Williams AC, Cornwell PA, Barry BW: On the non-Gaussian distribution of human skin permeabilities. Int J Pharm 1992; 86:69-77.
19. Walstra P: Formation of emulsions; in Becher P (ed): Encyclopedia of Emulsion Technology. New York, Dekker, 1983, vol 1, pp 57-127.
20. Barry BW: Percutaneous absorption; in Barry BW (ed): Dermatological Formulations. New York, Dekker, 1983, vol 18, pp 1-48.
21. Hadgraft J: Skin, the final frontier. Int J Pharm 2001;224:1-18.
22. Ashton P, Walters KA, Brain KR, Hadgraft J: Surfactant effects in percutaneous absorption. I. Effect on the transdermal flux of methyl nicotinate. Int J Pharm 1992;87:261-264.
23. Ruddy SB: Surfactants; in Smith EW, Maibach HI (eds): Percutaneous Penetration Enhancers. Florida, CRC Press, 1995, pp 245-257.